Vestal Point Capital, LP BDTX Black Diamond Therapeutics Inc

Ownership history in Vestal Point Capital, LP  ·  7 quarters on record

AI Ownership Summary

Vestal Point Capital, LP reported Black Diamond Therapeutics Inc (BDTX) in 7 quarterly 13F filings from 2024 Q2 through 2025 Q4. Peak portfolio weight reached 1.66% in 2024 Q3. The latest visible filing shows BDTX at 0.07% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this BDTX ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Vestal Point Capital, LP's position in Black Diamond Therapeutics Inc, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2025 Q4

BDTX was reported at 0.07% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
1.66% in 2024 Q3

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q2 to 2025 Q4

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

How Vestal Point Capital, LP held BDTX — position size vs. price
% of Fund (quarterly)    BDTX price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 7 quarters  
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2025 Q4 REDUCED 84.3% -12.3% 870,000 -4,680,000 -84.3% 0.07% $2.1M 2026-02-17 $2.23
2025 Q3 REDUCED 5,550,000 -50,000 -0.9% 0.95% $21.0M 2025-11-14 $4.01
2025 Q2 UNCHANGED 5,600,000 0% 0.73% $13.9M 2025-08-14 $2.79
2025 Q1 UNCHANGED 5,600,000 0% 0.62% $8.7M 2025-05-15 $1.93
2024 Q4 ADDED 5,600,000 +571,500 +11.4% 0.71% $12.0M 2025-02-14 $2.37
2024 Q3 ADDED 5,028,500 +2,928,500 +139.5% 1.66% $21.9M 2024-11-14 $2.85
2024 Q2 INITIATED 2,100,000 0.73% $9.8M 2024-08-14 $5.00

FAQ About Vestal Point Capital, LP and BDTX

These are the practical questions this page is built to answer before you even open the full history table.

How long has Vestal Point Capital, LP reported owning BDTX?

Vestal Point Capital, LP reported BDTX across 7 quarterly 13F filings, from 2024 Q2 through 2025 Q4.

What was the largest reported BDTX position in Vestal Point Capital, LP's portfolio?

The largest reported portfolio weight for BDTX was 1.66% in 2024 Q3.

What is the latest reported BDTX position on this page?

The most recent filing on this page is 2025 Q4, when Vestal Point Capital, LP reported 870,000 shares, equal to 0.07% of portfolio, with an estimated market value of $2.1M.

What does the chart on this BDTX ownership page compare?

The chart compares Vestal Point Capital, LP's quarterly BDTX portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did Vestal Point Capital, LP time their BDTX position?

Based on 13F filing dates vs. subsequent BDTX price moves, Vestal Point Capital, LP correctly timed 1 out of 4 reported position changes (25%). The annualised alpha on BDTX relative to SPY over the holding period was -50.2%.

← Back to Vestal Point Capital, LP Holdings